Diploma PLC (LON:DPLM - Get Free Report) insider Johnny Thomson sold 26,794 shares of the firm's stock in a transaction that occurred on Tuesday, November 19th. The stock was sold at an average price of GBX 4,536 ($57.40), for a total transaction of £1,215,375.84 ($1,537,866.43).
Diploma Stock Down 1.2 %
DPLM stock opened at GBX 4,124 ($52.18) on Thursday. The firm has a market capitalization of £5.53 billion, a PE ratio of 4,825.58, a P/E/G ratio of 2.82 and a beta of 0.75. The company has a debt-to-equity ratio of 45.69, a current ratio of 2.27 and a quick ratio of 0.80. The company's 50 day simple moving average is GBX 4,394.26 and its 200-day simple moving average is GBX 4,266.49. Diploma PLC has a 12 month low of GBX 3,200 ($40.49) and a 12 month high of GBX 4,653 ($58.88).
Diploma Increases Dividend
The firm also recently declared a dividend, which will be paid on Friday, January 31st. Shareholders of record on Thursday, January 16th will be paid a GBX 42 ($0.53) dividend. This represents a yield of 0.93%. This is a positive change from Diploma's previous dividend of $17.30. The ex-dividend date of this dividend is Thursday, January 16th. Diploma's dividend payout ratio (DPR) is presently 6,627.91%.
Wall Street Analysts Forecast Growth
Separately, Shore Capital downgraded shares of Diploma to a "hold" rating in a research report on Tuesday.
Read Our Latest Analysis on DPLM
About Diploma
(
Get Free Report)
Blackrock’s Sending THIS Crypto Higher on Purpose
From Crypto 101 Media | Ad
It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development…
YES, I WANT THE #1 CRYPTO NOW
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
